文献速递骨肌CTSPECT

放射性核素骨SPECT/CT在膝关节疼痛评估中的应用:与两时相骨闪烁显像、SPECT的对比研究

Radionuclide bone SPECT/CT in the evaluation of knee pain: comparing two-phase bone scintigraphy, SPECT and SPECT/CT.
PubMed 文献 · Br J Radiol · 2018-09-11

该回顾性研究直接比较了骨闪烁显像(BS)、SPECT和SPECT/CT在39例患者65个膝关节105个病灶中的病灶检出、定位和定性能力。SPECT/CT在病灶定位和定性上显著优于BS和SPECT(p<0.01),并能检出全部与骨关节炎共存的致病/促进/相关病变,作者认为SPECT/CT可考虑用于膝关节疼痛评估。

要点

  • SPECT/CT对病灶定位和定性均达100%,显著优于BS和SPECT(p<0.01)。
  • SPECT和SPECT/CT病灶检出率均为100%,显著高于BS的91.4%(p<0.05)。
  • SPECT/CT检出100%与骨关节炎共存的致病/促进/相关病变,而BS和SPECT均未检出。

核心结论

  • SPECT/CT在基于病灶、基于膝关节和基于患者分析中均较BS和SPECT有显著增量价值。
  • 作者认为SPECT/CT是MRI的可行替代方案,在膝关节疼痛评估中可考虑在BS和SPECT基础上加做SPECT/CT。

研究设计与样本

  • 回顾性研究,纳入39例患者共65个膝关节、105个病灶,直接比较BS、SPECT和SPECT/CT的病灶检出、定位和定性。

关键影像表现/征象

  • BS病灶检出率为91.4%,SPECT和SPECT/CT均为100%,SPECT和SPECT/CT检出病灶数显著多于BS(p<0.05)。
  • BS病灶定位率为38.5-41.7%,SPECT为74.4-83.3%,SPECT/CT为100%,SPECT/CT定位病灶数显著多于BS和SPECT(p<0.01)。
  • BS病灶定性率为23.0-52.1%,SPECT为30.8-56.2%,SPECT/CT为92.3-96.9%,SPECT/CT定性病灶数显著多于BS和SPECT(p<0.01)。
  • 非关节病病灶定性率:BS为6.25%,SPECT为12.5%,SPECT/CT为93.75%,SPECT/CT显著多于BS和SPECT(p<0.01)。
  • 与骨关节炎共存的致病/促进/相关病变:BS和SPECT均未检出,SPECT/CT检出100%。

诊断标准与关键数值

  • 原文未报告敏感度、特异度、AUC、阈值或分级标准。

临床应用与阅片要点

  • 作者认为SPECT/CT是MRI的可行替代方案。
  • 作者认为在膝关节疼痛评估中可考虑在BS和SPECT基础上加做SPECT/CT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: To assess the role of single photon emission computed tomography (SPECT/CT) in the evaluation of knee pain as well as comparing bone scintigraphy (BS), SPECT and SPECT/CT, and assessing the incremental value of SPECT/CT.

METHODS:: BS, SPECT and SPECT/CT of patients with knee pain (39 patients, 65 knees, 105 lesions) were directly compared for lesion detection, localisation and characterisation using lesion-based, knee-based and patient-based analyses in this retrospective study.

RESULTS:: Lesion detection: BS (91.4%), SPECT (100%) and SPECT/CT (100%). SPECT and SPECT/CT detected significantly more lesions than BS (p < 0.05). Lesion localisation: BS (38.5-41.7%), SPECT (74.4-83.3%) and SPECT/CT (100%). SPECT localised significantly more lesions than BS; SPECT/CT localised significantly more lesions than BS and SPECT (p < 0.01). Lesion characterisation: BS (23.0-52.1%), SPECT (30.8-56.2%) and SPECT/CT (92.3-96.9%). SPECT/CT characterised significantly more lesions than BS and SPECT (p < 0.01). Characterisation of non-arthropathy lesions: BS (6.25%), SPECT (12.5%) and SPECT/CT (93.75%). SPECT/CT characterised significantly more non-arthropathy lesions than BS and SPECT (p < 0.01). BS and SPECT detected none, while SPECT/CT detected 100% of the causative/contributing/associated conditions that co-existed with osteoarthritis. Therefore SPECT/CT detected not only just osteoarthritis but also the causative/contributing/associated conditions.

CONCLUSION:: SPECT/CT added significant incremental value to BS and SPECT irrespective of whether evaluation was lesion-based, knee-based or patient-based. SPECT/CT represents a viable alternative to MRI, and addition of SPECT/CT to BS and SPECT should be considered in the evaluation of knee pain.

ADVANCES IN KNOWLEDGE:: Incremental value of bone SPECT/CT in knee pain.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Lu SJ, Ul Hassan F, Vijayanathan S, et al. Radionuclide bone SPECT/CT in the evaluation of knee pain: comparing two-phase bone scintigraphy, SPECT and SPECT/CT. Br J Radiol. 2018. PMID: 29906234. doi:10.1259/bjr.20180168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。